EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Small Intestine-Targeted Long-Acting Oral Insulin Formulation Based on Engineered Milk Protein Nanoparticles

Anbu Mozhi Thamizhchelvan iD, Yuancheng Li iD, Jonathan Padelford, Ce Yang, Chunhua Yang iD, Peijian He, Ashan Galhena, Tianhe Wu, Malgorzata Lipowska, Hui Mao iD

ACS Applied Bio Materials · 2026

DOI: 10.1021/acsabm.5c02114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Bio Materials, 2026. Verfasst von Anbu Mozhi Thamizhchelvan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, United States. Hauptthemen laut MEDLINE: Insulin, Intestine, Small, Nanoparticles, Biocompatible Materials. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIDDK NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinIntestine, SmallNanoparticlesBiocompatible MaterialsHypoglycemic AgentsMilk ProteinsAnimalsAdministration, OralMiceParticle SizeMaterials TestingCaseinsMale

Stichwörter der Autor:innen

diabetesinsulinlong actingmilk proteinnanoparticleoral delivery

Substanzen

InsulinBiocompatible MaterialsHypoglycemic AgentsMilk ProteinsCaseins

Autor:innen und Institutionen

  • Department of Radiology and Imaging Sciences, Emory University School of Medicine, Atlanta, Georgia 30322, United States.
  • 5M Biomed, LLC, Atlanta, Georgia 30303, United States.
  • Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia 30303, United States.
  • Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30322, United States.

ORCID-Profile: Anbu Mozhi Thamizhchelvan, Yuancheng Li, Chunhua Yang, Hui Mao

Förderung

  • NCI NIH HHS
  • NIDDK NIH HHS
  • National Cancer Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • School of Medicine, Emory University

Zitieren

APA

Thamizhchelvan, A. M., Li, Y., Padelford, J., Yang, C., Yang, C., He, P., Galhena, A., Wu, T., Lipowska, M., & Mao, H. (2026). Small Intestine-Targeted Long-Acting Oral Insulin Formulation Based on Engineered Milk Protein Nanoparticles. ACS Applied Bio Materials. https://doi.org/10.1021/acsabm.5c02114

Vancouver

Thamizhchelvan AM, Li Y, Padelford J, Yang C, Yang C, He P, et al. Small Intestine-Targeted Long-Acting Oral Insulin Formulation Based on Engineered Milk Protein Nanoparticles. ACS Applied Bio Materials. 2026. doi:10.1021/acsabm.5c02114

BibTeX
@article{Thamizhchelvan2026,
  author = {Thamizhchelvan, Anbu Mozhi and Li, Yuancheng and Padelford, Jonathan and Yang, Ce and Yang, Chunhua and He, Peijian and Galhena, Ashan and Wu, Tianhe and Lipowska, Malgorzata and Mao, Hui},
  title = {Small Intestine-Targeted Long-Acting Oral Insulin Formulation Based on Engineered Milk Protein Nanoparticles},
  journal = {ACS Applied Bio Materials},
  year = {2026},
  doi = {10.1021/acsabm.5c02114}
}
Kostenlos starten →